Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Restorelle Direct Fix A&P for Female Pelvic Organ Prolapse: A Prospective Post Market Study

NCT01378065 is registered in ClinicalTrials.gov with Coloplast A/S as lead sponsor.

NCT NCT01378065
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01378065 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Restorelle Direct Fix A&P for Female Pelvic Organ Prolapse: A Prospective Post Market Study
Lead sponsor
Coloplast A/S
Phase
Observational
Overall status
Completed
Start date
June 30, 2011
Completion date
September 30, 2013
Enrollment
31 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

pelvic organ prolapse (pop)